LUPUS AWARENESS MONTH LUPUS FACT OF THE DAY: In 2011, the first lupus therapy in 50 years was approved with Benlysta (belimumab). Co-developed with Human Genome Sciences and GlaxoSmithKline, Belimumab is an antibody that interferes with the immune systems assault by binding to and inhibiting a protein called the B-lymphocyte stimulator (BLyS). Blocking BLyS is thought to cause the immune systems antibody-producing B cells to self-destruct, thereby reducing the bodys ability to attack its own tissues. Share this fact on your FB page to help educate and raise awareness of lupus during the month of May.
Posted on: Wed, 21 May 2014 16:43:55 +0000
Trending Topics
Recently Viewed Topics
© 2015